छोड़कर सामग्री पर जाएँ
RBI makes no change to FY24 inflation forecast, implies sub-5% CPI in September

RBI makes no change to FY24 inflation forecast, implies sub-5% CPI in September

  • द्वारा
  • Latest News

RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August, well above the upper bound of the central bank#39;s tolerance range of 2-6 percent

Read More

​ RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August, well above the upper bound of the central bank#39;s tolerance range of 2-6 percent RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August, well above the upper bound of the central bank#39;s tolerance range of 2-6 percent  Moneycontrol Latest News Read More  

RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August, well above the upper bound of the central bank#39;s tolerance range of 2-6 percent

Emerging economies face China and rate pressures as IMF, World Bank meet

Emerging economies face China and rate pressures as IMF, World Bank meet

  • द्वारा
  • Latest News

Restructuring efforts for defaulted countries could reach a breakthrough before year-end as talks continue, while the finances of nations like Pakistan and Egypt will also be under scrutiny when policy makers and asset managers gather for the World Bank and International Monetary Fund#39;s annual meetings in Marrakech next week.

Read More

​ Restructuring efforts for defaulted countries could reach a breakthrough before year-end as talks continue, while the finances of nations like Pakistan and Egypt will also be under scrutiny when policy makers and asset managers gather for the World Bank and International Monetary Fund#39;s annual meetings in Marrakech next week. Restructuring efforts for defaulted countries could reach a breakthrough before year-end as talks continue, while the finances of nations like Pakistan and Egypt will also be under scrutiny when policy makers and asset managers gather for the World Bank and International Monetary Fund#39;s annual meetings in Marrakech next week.  Moneycontrol Latest News Read More  

Restructuring efforts for defaulted countries could reach a breakthrough before year-end as talks continue, while the finances of nations like Pakistan and Egypt will also be under scrutiny when policy makers and asset managers gather for the World Bank and International Monetary Fund#39;s annual meetings in Marrakech next week.

India among top 3 nations with highest 5G base, roll-out remarkable: Nokia CEO Pekka Lundmark

India among top 3 nations with highest 5G base, roll-out remarkable: Nokia CEO Pekka Lundmark

  • द्वारा
  • Latest News

Nokia President and CEO Pekka Lundmark was addressing an event during the inauguration of the company#39;s 6G research lab in Bengaluru on Thursday. “5G roll-out in India is truly remarkable.

Read More

​ Nokia President and CEO Pekka Lundmark was addressing an event during the inauguration of the company#39;s 6G research lab in Bengaluru on Thursday. “5G roll-out in India is truly remarkable. Nokia President and CEO Pekka Lundmark was addressing an event during the inauguration of the company#39;s 6G research lab in Bengaluru on Thursday. “5G roll-out in India is truly remarkable.  Moneycontrol Latest News Read More  

Nokia President and CEO Pekka Lundmark was addressing an event during the inauguration of the company#39;s 6G research lab in Bengaluru on Thursday. “5G roll-out in India is truly remarkable.

Kalyan Jewellers in the green as revenue from India operations grows 32% YoY

Kalyan Jewellers in the green as revenue from India operations grows 32% YoY

  • द्वारा
  • Latest News

Apart from announcing the percentage growth in revenue for the quarter, the company said that it had opened 13 new showrooms across non-south markets in the quarter and further aims to launch 26 showrooms in the next 40 days.

Read More

​ Apart from announcing the percentage growth in revenue for the quarter, the company said that it had opened 13 new showrooms across non-south markets in the quarter and further aims to launch 26 showrooms in the next 40 days. Apart from announcing the percentage growth in revenue for the quarter, the company said that it had opened 13 new showrooms across non-south markets in the quarter and further aims to launch 26 showrooms in the next 40 days.  Moneycontrol Latest News Read More  

Apart from announcing the percentage growth in revenue for the quarter, the company said that it had opened 13 new showrooms across non-south markets in the quarter and further aims to launch 26 showrooms in the next 40 days.

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

  • द्वारा
  • Latest News

13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent

Read More

​ 13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent 13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent  Moneycontrol Latest News Read More  

13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent

Adani Wilmar shares gain 1%; reports strong double-digit volume growth in Q2

Adani Wilmar shares gain 1%; reports strong double-digit volume growth in Q2

  • द्वारा
  • Latest News

Nuvama maintained its #39;Buy#39; call on Adani Wilmar, with a 12-month target price of Rs 600 per equity share

Read More

​ Nuvama maintained its #39;Buy#39; call on Adani Wilmar, with a 12-month target price of Rs 600 per equity share Nuvama maintained its #39;Buy#39; call on Adani Wilmar, with a 12-month target price of Rs 600 per equity share  Moneycontrol Latest News Read More  

Nuvama maintained its #39;Buy#39; call on Adani Wilmar, with a 12-month target price of Rs 600 per equity share

Rate-sensitive stocks trades higher ahead of RBI policy decision

Rate-sensitive stocks trades higher ahead of RBI policy decision

  • द्वारा
  • Latest News

The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said

Read More

​ The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said  Moneycontrol Latest News Read More  

The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said

Rate-sensitive stocks trades higher ahead of RBI policy decision

Rate-sensitive stocks trades higher ahead of RBI policy decision

  • द्वारा
  • Latest News

The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said

Read More

​ The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said  Moneycontrol Latest News Read More  

The RBI is expected to hold rates. It will be business as usual if the central bank leaves policy rates unchanged but a tinkering can lead to a sharp gyration in the market, analysts have said

Valiant Laboratories lists at Rs 162, a 16% premium to IPO price

Valiant Laboratories lists at Rs 162, a 16% premium to IPO price

  • द्वारा
  • Latest News

Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol

Read More

​ Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol  Moneycontrol Latest News Read More  

Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol

Mankind Pharma down as Sikkim floods disrupt operations

Mankind Pharma down as Sikkim floods disrupt operations

  • द्वारा
  • Latest News

In the past three months, the stock has risen over 2 percent against a 0.3 percent decline in the Sensex

Read More

​ In the past three months, the stock has risen over 2 percent against a 0.3 percent decline in the Sensex In the past three months, the stock has risen over 2 percent against a 0.3 percent decline in the Sensex  Moneycontrol Latest News Read More  

In the past three months, the stock has risen over 2 percent against a 0.3 percent decline in the Sensex

hi_INहिन्दी